Telomerace Recruitment to Telomeres Via Core Telomore Binding Proteins
Telomerace Recruitment to Telomeres Via Core Telomore Binding Proteins
批准号:
7885409
负责人:
Eladio Beris Abreu
金额:
$2.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-17 至 2011-06-16
关键词:
AdultAmericanBindingBinding ProteinsBiogenesisBiological AssayCause of DeathCell CycleChromosomesComplexDNADevelopmentDiseaseEnzymesEthnic groupEventFluorescence MicroscopyGeneticHealthHumanHuman ChromosomesIn VitroKnowledgeLengthMaintenanceMalignant NeoplasmsMediatingMitoticModelingMolecularNatureNuclearPatternPhasePopulationProcessRegulationRetroviral VectorRibonucleoproteinsRoleSiteSocietiesSolidSomatic CellStructureTechniquesTelomeraseTelomerase RNA ComponentTelomere-Binding ProteinsTestingTherapeutic Human ExperimentationTissuesWorkanti-cancer therapeuticbasecancer cellcell typecombatenzyme activityin vivoinsightmutantoverexpressionprenatalprotein complexpublic health relevanceracial and ethnicsenescencetelomerase reverse transcriptasetelomeretraffickingtumor
中文摘要
描述(由申请人提供):人类染色体的末端由称为端粒的dna -蛋白质复合物保护。在成年体细胞中,端粒逐渐缩短,直到达到一个临界的短长度,导致衰老或危机。这个过程限制了大多数细胞类型的增殖能力。端粒酶是负责合成组成端粒的重复DNA的酶。我们的实验室主要致力于了解端粒酶核心成分的细胞内运输的分子基础:端粒酶RNA (hTR)和端粒酶逆转录酶(hTERT)。我们假设端粒酶的募集是在细胞周期的s期触发的,并通过端粒酶与核心端粒结合蛋白的动态结合而促进。我们实验室开发的荧光显微镜技术将被用于各种检测中,以评估端粒酶的内在作用,以及一组核心端粒结合蛋白在促进端粒募集中的作用。我们已经定义了两个特定的目标:aim1 - hTERT在端粒酶靶向端粒端的作用将被剖析。这将通过测试一组hTERT突变体在多种细胞类型中靶向端粒酶的能力来完成。此外,体外结合试验将确定hTERT的哪些结构域对TPP1的结合至关重要,TPP1是核心端粒结合蛋白中的中心招募候选者。
英文摘要
DESCRIPTION (provided by applicant): The ends of human chromosomes are protected by DNA-protein complexes called telomeres. In adult somatic cells, telomeres progressively shorten until reaching a critically short length, resulting in senescence or crisis. This process limits the proliferative capacity of most cell types. Telomerase is the enzyme responsible for synthesizing the repetitive DNA that comprises the telomere. Our lab is primarily focusing on understanding the molecular basis for the intracellular trafficking of the core components of telomerase: telomerase RNA (hTR), and telomerase reverse transcriptase (hTERT). We hypothesize that the recruitment of telomerase is triggered during S-phase of the cell cycle and is facilitated by the dynamic association of the enzyme with core telomere binding proteins. Fluorescence microscopy techniques developed by our lab will be employed in a variety of assays to assess the intrinsic roles of telomerase, as well as those of a panel of core telomere binding proteins, in facilitating recruitment to telomeres. We have defined two specific aims: Aim1-The role of hTERT in targeting telomerase to the telomere end will be dissected. This will be accomplished by testing the ability of a panel of hTERT mutants to target telomerase to telomeres in multiple cell types. Additionally, in vitro binding assays will determine which domains of hTERT are critical for binding TPP1, the central recruitment candidate among core telomere binding proteins.
Aim 2-The role of core telomere binding proteins in mediating telomerase recruitment to telomeres will be determined. The effects of RNAI mediated depletion and retroviral vector assisted overexpression of each core telomere binding protein on the recruitment of both hTR and hTERT will be contrasted. Recruitment candidates identified in this manner will become the focus of additional mutational analysis to identify their contribution(s) to telomerase recruitment. Public Health Relevance: Cancer has become a serious threat to the health of our society. This disease does not discriminate, proving to be a leading cause of death shared among the diverse racial and ethnic groups that make up the american population. Telomerase is reactivation is critical to prolonged tumor maintenance and proliferation in nearly all cancers. The characterization of hTERT association with core telomere binding proteins should contribute significantly to our understanding of the dynamic mechanism of telomerase regulation through recruitment and trafficking. This may prove invaluable in developing new ways to inhibit telomerase and combat the vast majority of cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金